BNTX logo

BioNTech SE (BNTX) Depreciation & Amortization

Annual D&A:

$322.34M+$124.07M(+62.57%)
December 31, 2024

Summary

  • As of today, BNTX annual D&A is $322.34 million, with the most recent change of +$124.07 million (+62.57%) on December 31, 2024.
  • During the last 3 years, BNTX annual D&A has risen by +$233.46 million (+262.65%).
  • BNTX annual D&A is now at all-time high.

Performance

BNTX Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly D&A:

$143.65M+$86.71M(+152.30%)
September 30, 2025

Summary

  • As of today, BNTX quarterly D&A is $143.65 million, with the most recent change of +$86.71 million (+152.30%) on September 30, 2025.
  • Over the past year, BNTX quarterly D&A has increased by +$95.24 million (+196.73%).
  • BNTX quarterly D&A is now -20.37% below its all-time high of $180.39 million, reached on December 31, 2024.

Performance

BNTX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM D&A:

$426.02M+$95.24M(+28.79%)
September 30, 2025

Summary

  • As of today, BNTX TTM D&A is $426.02 million, with the most recent change of +$95.24 million (+28.79%) on September 30, 2025.
  • Over the past year, BNTX TTM D&A has increased by +$199.17 million (+87.80%).
  • BNTX TTM D&A is now at all-time high.

Performance

BNTX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

BNTX Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+62.6%+196.7%+87.8%
3Y3 Years+262.6%+325.0%+226.5%
5Y5 Years+749.7%+1312.6%+953.2%

BNTX Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+262.6%-20.4%+409.3%at high+231.3%
5Y5-Yearat high+749.7%-20.4%+1312.6%at high+953.2%
All-TimeAll-Timeat high+2688.7%-20.4%+1660.0%at high+5119.8%

BNTX Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$143.65M(+152.3%)
$426.02M(+28.8%)
Jun 2025
-
$56.94M(+26.4%)
$330.79M(+1.0%)
Mar 2025
-
$45.05M(-75.0%)
$327.55M(+1.1%)
Dec 2024
$322.34M(+62.6%)
$180.39M(+272.6%)
$324.07M(+42.9%)
Sep 2024
-
$48.41M(-9.9%)
$226.85M(+1.4%)
Jun 2024
-
$53.70M(+29.2%)
$223.64M(+9.2%)
Mar 2024
-
$41.57M(-50.0%)
$204.84M(+4.0%)
Dec 2023
$198.28M(+53.0%)
$83.17M(+84.0%)
$196.97M(+38.7%)
Sep 2023
-
$45.20M(+29.5%)
$142.00M(+8.7%)
Jun 2023
-
$34.91M(+3.6%)
$130.60M(-0.6%)
Mar 2023
-
$33.69M(+19.5%)
$131.33M(+2.1%)
Dec 2022
$129.59M
$28.20M(-16.6%)
$128.60M(-1.4%)
Sep 2022
-
$33.80M(-5.1%)
$130.47M(+8.6%)
Jun 2022
-
$35.63M(+15.1%)
$120.17M(+15.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
$30.96M(+2.9%)
$104.28M(+17.2%)
Dec 2021
$88.89M(+101.2%)
$30.08M(+28.0%)
$88.98M(+20.3%)
Sep 2021
-
$23.50M(+19.0%)
$73.98M(+22.0%)
Jun 2021
-
$19.75M(+26.1%)
$60.65M(+20.0%)
Mar 2021
-
$15.66M(+3.8%)
$50.55M(+14.0%)
Dec 2020
$44.17M(+16.4%)
$15.08M(+48.3%)
$44.36M(+9.7%)
Sep 2020
-
$10.17M(+5.4%)
$40.45M(+2.3%)
Jun 2020
-
$9.65M(+1.9%)
$39.54M(+0.7%)
Mar 2020
-
$9.47M(-15.2%)
$39.26M(+3.4%)
Dec 2019
$37.94M(+46.3%)
$11.17M(+20.6%)
$37.95M(+41.7%)
Sep 2019
-
$9.26M(-1.0%)
$26.78M(+52.9%)
Jun 2019
-
$9.36M(+14.7%)
$17.52M(+114.7%)
Mar 2019
-
$8.16M
$8.16M
Dec 2018
$25.94M(+124.4%)
-
-
Dec 2017
$11.56M
-
-

FAQ

  • What is BioNTech SE annual D&A?
  • What is the all-time high annual D&A for BioNTech SE?
  • What is BioNTech SE annual D&A year-on-year change?
  • What is BioNTech SE quarterly D&A?
  • What is the all-time high quarterly D&A for BioNTech SE?
  • What is BioNTech SE quarterly D&A year-on-year change?
  • What is BioNTech SE TTM D&A?
  • What is the all-time high TTM D&A for BioNTech SE?
  • What is BioNTech SE TTM D&A year-on-year change?

What is BioNTech SE annual D&A?

The current annual D&A of BNTX is $322.34M

What is the all-time high annual D&A for BioNTech SE?

BioNTech SE all-time high annual D&A is $322.34M

What is BioNTech SE annual D&A year-on-year change?

Over the past year, BNTX annual D&A has changed by +$124.07M (+62.57%)

What is BioNTech SE quarterly D&A?

The current quarterly D&A of BNTX is $143.65M

What is the all-time high quarterly D&A for BioNTech SE?

BioNTech SE all-time high quarterly D&A is $180.39M

What is BioNTech SE quarterly D&A year-on-year change?

Over the past year, BNTX quarterly D&A has changed by +$95.24M (+196.73%)

What is BioNTech SE TTM D&A?

The current TTM D&A of BNTX is $426.02M

What is the all-time high TTM D&A for BioNTech SE?

BioNTech SE all-time high TTM D&A is $426.02M

What is BioNTech SE TTM D&A year-on-year change?

Over the past year, BNTX TTM D&A has changed by +$199.17M (+87.80%)
On this page